However, natural products can target to oncogenic signaling molecules STAT3, which may affect STAT3-associated PD-1+CD8+ T cells and IL-6/STAT3/PD-1 transcription regulation systems in the tumor microenvironment, ultimately controlling the generation and progression of drug resistance (235, 236). This evidence concerns the gene PDCD1 and neoplasm.